12:00 AM
 | 
Nov 25, 2013
 |  BC Week In Review  |  Company News  |  Other News

Bioviron, Life & Brain, Microvitae Technologies, to-BBB, Academisch Medisch Centrum, Aix Marseille Universite, Ben-Gurion University of the Negev, Imperial Coll

A consortium led by the University of Lund received a €11.9 million ($16.1 million) grant from the EU's Framework Programme 7 (FP7) to identify biomarkers of epileptogenesis and develop therapeutics to prevent progression to epilepsy. The five-year EPITARGET consortium comprises 13 academic institutions and four small- and medium-sized entities. to-BBB will receive €750,000...

Read the full 245 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >